PreClinical |
Preclinical Imaging
Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. Gamma Medica is the first company to have developed and made commercially available a trimodality system. The Triumph™ System is a multi-modality pre-clinical imaging platform offering multiple configurations to meet your needs.
Gamma Medica Pre-Clinical Imaging Division products, click on the following:
 European Service Contact: This e-mail address is being protected from spambots. You need JavaScript enabled to view it |